RSS icon

Top Stories

Specialty Drugs Appearing as the Next Wave of Health Care Costs

The Midwest Business Group on Health and other organizations aim to educate employers about the cost of biologics, which treat serious illnesses such as cancer. Their cost is expected to rise to 40 percent of employers' total drug costs by 2017.

September 28, 2012
Related Topics: Health Care Costs, Top Stories - Frontpage, Health and Wellness, Benefits
Reprints
To view the full article, please register or login.